350 related articles for article (PubMed ID: 19151727)
41. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
42. The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity.
Lisowska J; Rödel CJ; Manet S; Miroshnikova YA; Boyault C; Planus E; De Mets R; Lee HH; Destaing O; Mertani H; Boulday G; Tournier-Lasserve E; Balland M; Abdelilah-Seyfried S; Albiges-Rizo C; Faurobert E
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 30030370
[TBL] [Abstract][Full Text] [Related]
43. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations.
Boulday G; Blécon A; Petit N; Chareyre F; Garcia LA; Niwa-Kawakita M; Giovannini M; Tournier-Lasserve E
Dis Model Mech; 2009; 2(3-4):168-77. PubMed ID: 19259391
[TBL] [Abstract][Full Text] [Related]
44. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
[TBL] [Abstract][Full Text] [Related]
45. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Cullere X; Plovie E; Bennett PM; MacRae CA; Mayadas TN
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14284-9. PubMed ID: 26540726
[TBL] [Abstract][Full Text] [Related]
46. A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
Wang H; Pan Y; Zhang Z; Li X; Xu Z; Suo Y; Li W; Wang Y
J Mol Neurosci; 2017 Feb; 61(2):221-226. PubMed ID: 28160210
[TBL] [Abstract][Full Text] [Related]
47. Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult.
Denier C; Gasc JM; Chapon F; Domenga V; Lescoat C; Joutel A; Tournier-Lasserve E
Mech Dev; 2002 Sep; 117(1-2):363-7. PubMed ID: 12204286
[TBL] [Abstract][Full Text] [Related]
48. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
[TBL] [Abstract][Full Text] [Related]
49. Cerebral cavernous malformation: new molecular and clinical insights.
Revencu N; Vikkula M
J Med Genet; 2006 Sep; 43(9):716-21. PubMed ID: 16571644
[TBL] [Abstract][Full Text] [Related]
50. Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.
Battistini S; Rocchi R; Cerase A; Citterio A; Tassi L; Lando G; Patrosso MC; Galli R; Brunori P; Sgrò DL; Pitillo G; Lo Russo G; Marocchi A; Penco S
Arch Neurol; 2007 Jun; 64(6):843-8. PubMed ID: 17562932
[TBL] [Abstract][Full Text] [Related]
51. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
[TBL] [Abstract][Full Text] [Related]
52. Review of familial cerebral cavernous malformations and report of seven additional families.
de Vos IJ; Vreeburg M; Koek GH; van Steensel MA
Am J Med Genet A; 2017 Feb; 173(2):338-351. PubMed ID: 27792856
[TBL] [Abstract][Full Text] [Related]
53. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution.
Orsenigo F; Conze LL; Jauhiainen S; Corada M; Lazzaroni F; Malinverno M; Sundell V; Cunha SI; Brännström J; Globisch MA; Maderna C; Lampugnani MG; Magnusson PU; Dejana E
Elife; 2020 Nov; 9():. PubMed ID: 33138917
[TBL] [Abstract][Full Text] [Related]
54. Notch Signaling in Familial Cerebral Cavernous Malformations and Immunohistochemical Detection of Cleaved Notch1 Intracellular Domain.
Hasan SS; Fischer A
Methods Mol Biol; 2020; 2152():427-435. PubMed ID: 32524570
[TBL] [Abstract][Full Text] [Related]
55. Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
Li W; Tran V; Shaked I; Xue B; Moore T; Lightle R; Kleinfeld D; Awad IA; Ginsberg MH
Elife; 2021 May; 10():. PubMed ID: 34013885
[TBL] [Abstract][Full Text] [Related]
56. ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.
Herberich SE; Klose R; Moll I; Yang WJ; Wüstehube-Lausch J; Fischer A
PLoS One; 2015; 10(12):e0145304. PubMed ID: 26698571
[TBL] [Abstract][Full Text] [Related]
57. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.
Fisher OS; Boggon TJ
Cell Mol Life Sci; 2014 May; 71(10):1881-92. PubMed ID: 24287896
[TBL] [Abstract][Full Text] [Related]
58. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.
Whitehead KJ; Chan AC; Navankasattusas S; Koh W; London NR; Ling J; Mayo AH; Drakos SG; Jones CA; Zhu W; Marchuk DA; Davis GE; Li DY
Nat Med; 2009 Feb; 15(2):177-84. PubMed ID: 19151728
[TBL] [Abstract][Full Text] [Related]
59. Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.
Glading AJ; Ginsberg MH
Dis Model Mech; 2010; 3(1-2):73-83. PubMed ID: 20007487
[TBL] [Abstract][Full Text] [Related]
60. Molecular diagnosis in cerebral cavernous malformations.
Mondejar R; Lucas M
Neurologia; 2017 Oct; 32(8):540-545. PubMed ID: 26304651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
